Benefits of Immunotherapy at Every Stage of Cancer

In the world of cancer treatment, time is a critical factor. The sooner the intervention, the better the outcomes. This is particularly true for immunotherapy, a groundbreaking treatment strategy that leverages the body’s immune system to combat cancer.

Triumph Over Stage 4 Melanoma: Brock’s Inspiring Journey

Brock S. had his world turned upside down when he was diagnosed with Stage 4 Melanoma in July 2022. With his cancer growing by 300% within five months since the initial diagnosis, he was given roughly three months to live.

Now six months after completing treatment and with remission in sight, Brock recently visited Immunocine to share his story.

Shining the Light on Vitamin D and Cancer Treatment

Worryingly, about 35-45% of Americans don’t have enough Vitamin D11, the essential nutrient that our bodies need for tasks like absorbing calcium in the gut and maintaining healthy bones^{2, 3.}

Babette’s Cancer Journey: Remarkable Progress and a Future in Sight

Babette’s journey with Immunocine is progressing steadily, and we’re excited to bring you another update on her path to recovery. Now nearly five months after completing her treatment, Babette continues to work with the Immunocine Team, who evaluate her medical reports and scans to closely to provide feedback.

Boosting Immunotherapy with Dietary Fiber

Of the 1.9 million cancer patients in 2021, 600,000 received immunotherapy, a remarkable number given the FDA approved the first cancer immunotherapy in 2011. This growth in the utilization of immunotherapy has spurred research into novel immunotherapies such as Immunocine’s Treatment, but also in supportive approaches to enhance immunotherapy.

Diet Guide to Prepare for Immunotherapy

As cancer patients prepare to come to Cancun to begin their personalized Immunotherapy journey, they often ask if there are things they can do to “improve the odds of success.” And while there are a few things, the focus here will be on diet and how it could improve the response of the Immunocine Therapy.

Immunocine Dendritic Cell Therapy for Colorectal Cancers

Colorectal cancers have been on the rise and now afflict more than 2 million humans per year, more than 150,000 Americans per year¹, and is simultaneously becoming one of the deadliest cancer categories across genders^{2, 3}.

Dendritic Cells and Their Therapeutic Role in Prostate Cancer

In 2022, almost 270,000 American men will be diagnosed with prostate cancer, and about 35,000 prostate cancer patients will succumb to the disease.

Babette’s Treatment Update

Babette has finally completed treatment at Immunocine. Now back home, the Immunocine Team will stay in contact with her to evaluate any future medical reports and scans. These follow ups are critical to ensure her physicians know what to expect going forward and Babette’s Immune System continues to attack her cancer.

Why Is Immunocine in Cancun, Mexico?

Alternative treatment centers are often met with a skeptical eye, and with justifiable reason.